Berry Street Capital Management Portfolio holdings

Berry Street Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Berry Street Capital Management held 45 positions worth $539M, up 36% from $397M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Berry Street Capital Management deployed $114M of net new capital in Q2 2023, opening 19 new positions and adding to 5 existing holdings. Its largest new stake was Syneos Health, Inc. Class A Common Stock: 312,500 shares worth $13.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $25.7M trimmed.

• Berry Street Capital Management's largest Q2 2023 buy was Syneos Health, Inc. Class A Common Stock: 312,500 shares worth $13.2M.
• Berry Street Capital Management added most to Activision Blizzard in Q2 2023, an estimated $18.2M increase.
• Berry Street Capital Management's biggest Q2 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $25.7M.
• Berry Street Capital Management fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $25.5M.
• Berry Street Capital Management's ten largest holdings make up 69% of its $539M portfolio in Q2 2023.
• Berry Street Capital Management opened 19 new positions and closed 15 in Q2 2023.
• Berry Street Capital Management's portfolio value rose 36% quarter-over-quarter to $539M.

Based on Berry Street Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.